PMRA.F 80.45 (+0.56%)
ES0169501022BiotechnologyBiotechnology

Pharma Mar (PMRA.F) Stock Highlights

80.45 | +0.56%
2024-12-21 04:02:38
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Statistics

Range Today
80.45 80.45
Volume Today 2
Range 1 Year
26.06 81.95
Volume 1 Year 1.85K
Range 3 Year
26.06 81.95
Volume 3 Year 13.19K
Range 10 Year
10.95 144.7
Volume 10 Year 159.93K

Highlights

Market Capitalization 1.44B (small)
Floating Shares 13.63M
Current Price 80.45
Price To Earnings 1.89K
Price To Revenue 7.39
Price To Book 7.28
Earnings Per Share 0.04
Dividend Yield 0.88%
Dividend Per Share 0.65
Payout Ratio 1.58K%

Performance

Latest +0.56%
1 Month +8.13%
3 Months +70.08%
6 Months +140.15%
1 Year +84.52%
3 Years +49.65%
5 Years +134.08%
10 Years +137.23%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.